{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:17:53Z","timestamp":1788913073454,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007602","name":"National Institute for Health Research Programme Grants for Applied Research","doi-asserted-by":"publisher","award":["NIHR204577"],"award-info":[{"award-number":["NIHR204577"]}],"id":[{"id":"10.13039\/501100007602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Developmental Disabilities"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ridd.2025.104968","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T18:54:37Z","timestamp":1741892077000},"page":"104968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Pattern of psychotropic prescribing in adults with intellectual disabilities in the community settings in the UK: A cross-sectional view"],"prefix":"10.1016","volume":"160","author":[{"given":"S.","family":"Deb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Limbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Allgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ridd.2025.104968_bib1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2788.1996.tb00641.x","article-title":"A review of antipsychotic drugs prescribed for people with learning disabilities who live in Leicestershire","volume":"40","author":"Branford","year":"1996","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2025.104968_bib2","first-page":"31","article-title":"Stopping over-medication of people with intellectual disability, autism or both (STOMP) in England Part 1\u2013History and background of STOMP","volume":"13","author":"Branford","year":"2018","journal-title":"Advances in Mental Health in Intellectual Disability"},{"key":"10.1016\/j.ridd.2025.104968_bib3","first-page":"1","article-title":"Antidepressant prescribing for adult people with an intellectual disability living in England","volume":"7","author":"Branford","year":"2022","journal-title":"British Journal of Psychiatry"},{"issue":"7","key":"10.1016\/j.ridd.2025.104968_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2788.2010.01275.x","article-title":"Use of antipsychotic drugs in individuals with intellectual disability (ID) in The Netherlands: Prevalence and reasons for prescription","volume":"54","author":"de Kuijper","year":"2010","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2025.104968_bib5","series-title":"Handbook of psychopathology in intellectual disability: Autism and Child Psychopathology series\u2019","first-page":"395","article-title":"Psychopharmacology","author":"Deb","year":"2024"},{"issue":"5","key":"10.1016\/j.ridd.2025.104968_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjo.2020.96","article-title":"Association between epilepsy and challenging behaviour in adults with intellectual disabilities: Systematic review and meta-analysis","volume":"6","author":"Deb","year":"2020","journal-title":"British Journal of Psychiatry Open"},{"key":"10.1016\/j.ridd.2025.104968_bib7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/hup.470090405","article-title":"The use of psychotropic medication in people with learning disability: Towards rational prescribing","volume":"9","author":"Deb","year":"1994","journal-title":"Human Psychopharmacology"},{"key":"10.1016\/j.ridd.2025.104968_bib8","article-title":"The prevalence and incidence of mental illness, challenging behaviour, and psychotropic medication prescribing in adults with intellectual disabilities between 2010 and 2022: Czech population-based cohort study","author":"Deb","year":"2025","journal-title":"Medrxiv"},{"issue":"3","key":"10.1016\/j.ridd.2025.104968_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/j.2051-5545.2009.tb00248.x","article-title":"International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities","volume":"8","author":"Deb","year":"2009","journal-title":"World Psychiatry"},{"key":"10.1016\/j.ridd.2025.104968_bib10","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1017\/S003329172300212X","article-title":"Randomised controlled trials of antipsychotics for people with autism spectrum disorder: A systematic review and a meta-analysis","volume":"53","author":"Deb","year":"2023","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1016\/j.ridd.2025.104968_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jir.12119","article-title":"Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour","volume":"59","author":"Deb","year":"2015","journal-title":"Journal of Intellectual Disability Research"},{"key":"10.1016\/j.ridd.2025.104968_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/acps.13669","article-title":"Antipsychotic agents in anxiety disorders: An umbrella review","volume":"149","author":"Garakani","year":"2024","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.ridd.2025.104968_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/19315864.2025.2471289","article-title":"Short-term PsychoEducation for Carers To Reduce Over Medication of people with intellectual disabilities Programme Development Project (SPECTROM PDP): A feasibility randomized controlled trial protocol","author":"Limbu","year":"2025","journal-title":"Journal of Mental Health Research in Intellectual Disabilities"},{"key":"10.1016\/j.ridd.2025.104968_bib14","series-title":"Psychotropic drugs and people with learning disabilities or autism","author":"Mehta","year":"2019"},{"key":"10.1016\/j.ridd.2025.104968_bib15","unstructured":"NICE (The National Institute for Health and Care Excellence). Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges. 2015. Available online: \u3008https:\/\/www.nice.org.uk\/guidance\/ng11\u3009 (Accessed on 16.01.25)."},{"key":"10.1016\/j.ridd.2025.104968_bib16","unstructured":"Royal College of Psychiatrists (2017). Use of licensed medicines for unlicensed applications in psychiatric practice. College Report CR210 (2nd edition). Royal College of Psychiatrists, London, UK. \u3008www.rcpsych.ac.uk\u3009 (accessed on 15th January 2025)."},{"key":"10.1016\/j.ridd.2025.104968_bib17","first-page":"h4326","article-title":"Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability","volume":"351","author":"Sheehan","year":"2015","journal-title":"UK Population-Based cohort Study British Medical Journal"},{"issue":"5","key":"10.1016\/j.ridd.2025.104968_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/00048674221149864","article-title":"Use of psychotropic medications in adults with intellectual disability: A systematic review and meta-analysis","volume":"57","author":"Song","year":"2023","journal-title":"Australian New Zealand Journal of Psychiatry"},{"key":"10.1016\/j.ridd.2025.104968_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1192\/pb.bp.109.027086","article-title":"Antipsychotic polypharmacy-confusion reigns","volume":"34","author":"Taylor","year":"2010","journal-title":"The Psychiatrist"}],"container-title":["Research in Developmental Disabilities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422225000526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891422225000526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:50:23Z","timestamp":1762314623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891422225000526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":19,"alternative-id":["S0891422225000526"],"URL":"https:\/\/doi.org\/10.1016\/j.ridd.2025.104968","relation":{},"ISSN":["0891-4222"],"issn-type":[{"value":"0891-4222","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pattern of psychotropic prescribing in adults with intellectual disabilities in the community settings in the UK: A cross-sectional view","name":"articletitle","label":"Article Title"},{"value":"Research in Developmental Disabilities","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ridd.2025.104968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104968"}}